Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-Style
- Development stage
- Unknown
- Lead developer
- Anglo-French Drugs & Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
L-Style is an oral nutritional supplement developed and marketed by Anglo-French Drugs & Industries. It is formulated as a combination of alpha lipoic acid, cyanocobalamin (vitamin B12), omega-3 fatty acids, chromium picolinate, and selenium dioxide. L-Style is indicated to reduce fatigue and weakness, lower oxidative stress, support brain and cognitive function, and assist in lowering cholesterol levels. The supplement acts through the synergistic antioxidant, neuroprotective, and lipid-supportive properties of its active ingredients.
- Brand names
- L-Style
- Other names
- L-Style Softgel CapsuleL-Style Tablets
Beyond the preview
Go deeper on L-Style.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L-Style.